Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics

BACKGROUND: Gliomas are the most common primary malignant brain tumors and have a poor prognosis. Early detection of gliomas is crucial to improve patient outcomes. Urine accumulates systematic body changes and thus serves as an excellent early biomarker source. METHODS: At the biomarker discovery p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jianqiang, Zhang, Jun, Wei, Jing, Zhao, Yuanli, Gao, Youhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398313/
https://www.ncbi.nlm.nih.gov/pubmed/32922940
http://dx.doi.org/10.1186/s41016-020-00190-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398313/
https://www.ncbi.nlm.nih.gov/pubmed/32922940
http://dx.doi.org/10.1186/s41016-020-00190-5

Ejemplares similares